Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
News
Treatment with a liposomal formulation of irinotecan — meaning the chemotherapy is wrapped up in tiny fatty spheres —was well-tolerated and partially reduced the tumor burden in 35% of heavily ... Read more